Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001415889-23-003856)

Filing Details

Accession Number:: 0001415889-23-003856
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-03-02 17:07:04
Reporting Period:: 2023-02-28

Accepted Time:: 2023-03-02 17:07:04
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1551152	Abbvie Inc.	ABBV	Pharmaceutical Preparations (2834)	320375147

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1832571	K. Elaine Sorg	1 N. Waukegan Road North Chicago IL 60064	Svp, Us Commercial Operations	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, $0.01 Par Value	Disposition	2023-02-28	19,850	$154.28	42,829	No	4	F	Direct
Common Stock, $0.01 Par Value	Acquisiton	2023-03-01	15,003	$93.50	57,832	No	4	M	Direct
Common Stock, $0.01 Par Value	Disposition	2023-03-01	15,003	$155.00	42,829	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	F	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Option (Right to Buy)	Disposition	2023-03-01	15,003	$93.50	15,003	$93.50

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2020-02-20	2030-02-19	No	4	M	Direct

Footnotes

Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.